Original Source(s)
Related Content
FDA Grants Traditional Approval to Iptacopan in Primary IgAN
Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.
July 17, 2026
-
2 min
Myopia Patterns in Intermittent Exotropia
New findings indicate intermittent exotropia may influence binocular ocular growth patterns without significantly increasing myopia risk
July 15, 2026
-
2 min